Lilly has 11 obesity drugs in its pipeline and wants to develop more treatments for Alzheimer’s disease, ALS and other brain diseases, CEO David Ricks said.
More Stories
Spot Bitcoin ETFs record $243 million in outflows as BTC dumps
Bitcoin ETFs recorded outflows of $243 millin as markets fell amid Iran’s missile attack on Israel. BTC price also fell,...
Michael Jordan’s 23XI Racing team sues NASCAR and CEO Jim France
Michael Jordan's racing team and fellow team Front Row Motorsports said NASCAR has used anticompetitive practices to prevent fair compensation...
Stellantis U.S. auto sales extend freefall in third quarter
Stellantis reported U.S. sales Tuesday of 305,294 from July through September, a 19.8% decline from the third quarter of 2023.
Artificial Intelligence Put My Dad Out Of A Job And I’m Worried
For about 10 years, my father has been my primary editor on Financial Samurai. When my father isn't available, my...
DEGEN surges 160% after Coinbase adds token to listing roadmap
Degen rose by more than 160% in 24 hours after Coinbase announced trading support for the Base token. io.net token...
BoE and FCA launch Digital Securities Sandbox to explore DLT
The DSS has the “potential to improve efficiency and reduce costs” in financial markets The sandbox will boost the UK’s...